It is well established that adults with obesity may also have elevated levels of systemic inflammation [17], and that weight loss interventions decrease circulating inflammatory markers such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) [17,18,19,20]. The gene discussed is IL6; the disease is Obesity.